Tibet Weixinkang Medicine Co Ltd (603676) - Total Liabilities

Latest as of March 2026: CN¥406.29 Million CNY ≈ $59.45 Million USD

Based on the latest financial reports, Tibet Weixinkang Medicine Co Ltd (603676) has total liabilities worth CN¥406.29 Million CNY (≈ $59.45 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Tibet Weixinkang Medicine Co Ltd growing its equity to track the company's year-over-year net asset growth rate.

Tibet Weixinkang Medicine Co Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Tibet Weixinkang Medicine Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Tibet Weixinkang Medicine Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Tibet Weixinkang Medicine Co Ltd Competitors by Total Liabilities

The table below lists competitors of Tibet Weixinkang Medicine Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
MTY Food Group Inc
TO:MTY
Canada CA$1.67 Billion
Indointernet Tbk PT
JK:EDGE
Indonesia Rp2.14 Trillion
MERSEN UNSP.ADR 1/5 EO 2
F:CBE0
Germany €1.01 Billion
More Provident Funds
TA:MPP
Israel ILA289.57 Million
Shenzhen Refond Optoelectronics Co Ltd
SHE:300241
China CN¥1.39 Billion
Rio2 Ltd
V:RIO
Canada CA$87.09 Million
MNRB Holdings Bhd
KLSE:6459
Malaysia RM10.34 Billion
Anhui Huamao Textile Co Ltd
SHE:000850
China CN¥2.71 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Tibet Weixinkang Medicine Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tibet Weixinkang Medicine Co Ltd (603676) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.74 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.26 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tibet Weixinkang Medicine Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tibet Weixinkang Medicine Co Ltd (2013–2025)

The table below shows the annual total liabilities of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥390.49 Million
≈ $57.14 Million
-16.61%
2024-12-31 CN¥468.24 Million
≈ $68.52 Million
+7.26%
2023-12-31 CN¥436.55 Million
≈ $63.88 Million
-1.71%
2022-12-31 CN¥444.13 Million
≈ $64.99 Million
+3.70%
2021-12-31 CN¥428.31 Million
≈ $62.67 Million
+13.65%
2020-12-31 CN¥376.85 Million
≈ $55.15 Million
+0.61%
2019-12-31 CN¥374.56 Million
≈ $54.81 Million
+11.04%
2018-12-31 CN¥337.33 Million
≈ $49.36 Million
+112.71%
2017-12-31 CN¥158.58 Million
≈ $23.21 Million
+70.64%
2016-12-31 CN¥92.94 Million
≈ $13.60 Million
-12.18%
2015-12-31 CN¥105.82 Million
≈ $15.49 Million
+37.27%
2014-12-31 CN¥77.09 Million
≈ $11.28 Million
+25.31%
2013-12-31 CN¥61.52 Million
≈ $9.00 Million
--

About Tibet Weixinkang Medicine Co Ltd

SHG:603676 China Drug Manufacturers - Specialty & Generic
Market Cap
$566.73 Million
CN¥3.87 Billion CNY
Market Cap Rank
#11586 Global
#3274 in China
Share Price
CN¥8.90
Change (1 day)
+1.48%
52-Week Range
CN¥8.04 - CN¥13.08
All Time High
CN¥24.05
About

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins; electrolyte supplements; intravenous iron, trace, electrolytes, and amino acids supplements; antibiotics; acetylcysteine solution for inhalation; medicine for liver diseases; and other special fields. I… Read more